AVITA Medical (RCEL) Stock Highlights

10.26 | +0%

2024-09-18 05:26:24

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. Its approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

Statistics

Range Today

10 10.42

Volume Today 97.9K

Range 1 Year

7.51 18.93

Volume 1 Year 49.55M

Range 3 Year

4.41 21.7

Volume 3 Year 124.15M

Range 10 Year

3.75 55.35

Volume 10 Year 198.28M

Highlights

Market Capitalization 266.65M (small)

Floating Shares 25.05M

Current Price 10.26

Price To Earnings -5.05

Price To Revenue 4.76

Price To Book 11.13

Earnings Per Share -1.94

Payout Ratio 0%

Performance

Latest 0%

1 Month +13%

3 Months +24.97%

6 Months -37.86%

1 Year -35.88%

3 Years -44.81%

5 Years -71.18%

10 Years +4.16%

Benchmarks

Market Capitalization

50 / 92

Gross Profits

62 / 85

Total Revenue

68 / 89

Total Rank

48 / 92

Free Cashflow

63 / 90

Performance 5 years

64 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.